MBIO News and Press, Mustang Bio Inc. From 01/21/21

Today, we take an in-depth look at Mustang Bio whose shares are up some 60% over the past month. The rally was preceded by over $800,000 worth of insider buying in mid-December by the company's CEO and one director. Can the rally continue? We provide an investment analysis on...

WORCESTER, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, sol...

Are Analysts Right About These Penny Stocks? In this article, we’re going to explore a few things about penny stocks , what they are, and how to do research. We’ll also talk a bit about 5 of these stocks that analysts rate a buy right now. So let’s dive in. ...

Biotech Penny Stocks To Watch With Recent Updates It’s funny to think that 2020 is almost over yet penny stocks remain a major focus for traders right now. One of the main reasons for this has been the unrelenting focus on volatility. Believe it or not, I think 2020 was p...

Biotech Penny Stocks To Watch Right Now If you’re looking for penny stocks for your watch list right now, do you know where to start? Assuming you know that penny stocks are defined as shares trading for less than $5, price is usually a place to begin. But where do you go aft...

Mustang Bio ([[MBIO]] +5.7%) has initiated Phase 1 single-center, two-arm clinical trial evaluating MB-101 (autologous IL13Rα2-CAR T cells) in leptomeningeal brain tumors (e.g., glioblastoma, ependymoma or medulloblastoma).The 30-subject trial will establish the safety a...

WORCESTER, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, sol...

Insiders Consider These Penny Stocks To Buy Now At some point, you’ve been introduced to penny stocks . Whether it was by a “buddy” with a “hot tip” or you saw something on a movie, you’ve been excited by something relating to these cheap st...

Gainers: Obalon Therapeutics (OBLN) +121%.Greenland Technologies (GTEC) +79%.Oncternal Therapeutics (ONCT) +61%.Eastman Kodak (KODK) +60%.Fate Therapeutics (FATE) +46%.Nkarta (NKTX) +44%.Constellation Pharmaceuticals (CNST) +34%.Gamida Cell (GMDA) +31%.EHang Holdings (EH) +30%.Tonix...

Gainers: Obalon Therapeutics (OBLN) +116%, Oncternal Therapeutics (ONCT) +77%, Fate Therapeutics (FATE) +41%, Constellation Pharmaceuticals (CNST) +33%, Nkarta (NKTX) +28%.Losers: scPharmaceuticals (SCPH) -33%, Aptose Biosciences (APTO) -...